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As described  in a  previous paper  (1),  application  of antigen  to living sensi- 
tized cells induces an immediate activation of a  cellular protease and its release 
into the extracellular fluid (culture chamber fluid). The cells, tissue monocytes, 
were  obtained  from  the  peritoneal  fluid  of sensitized  rabbits  and  grown  in  a 
special culture chamber which allows a  parallel biochemical and morphological 
study  of the  cells.  The protease  appears  to  be an  SH  enzyme,  differing from 
trypsin or plasmin, and its optimum pH is around  7.4. 
In  the  same  experiments,  however,  proteolytic  activity  of  the  chamber 
fluid  was seen  to  decrease  after a  certain  time  (1).  There  remained  therefore 
to investigate  the  cause of the  decrease in protease activity observed in sam- 
ples of culture fluid collected at later stages of the reaction. 
The  purpose  of this  communication  is  to  present  experimental  data  which 
show that the decrease in protease activity of the chamber fluid is caused by an 
inhibitor  released from cultured  cells after the antigen-antibody  reaction.  The 
inhibitor  has  been  partially  purified  and  tested  for its  action  on  the  cellular 
protease and other proteolytic enzymes. 
Materials and Methods 
Details of the experimental procedures, such as sensitization of rabbits with bovine plasma 
albumin (Cohn fraction V), cultivation of tissue monocytes from the peritoneal  fluid, applica- 
tion of the antigen  to cultured cells, and assay of protease activity of chamber fluid samples 
have sll been given in previous papers (1-3). 
The eugiobulin fraction, used in this experiment, was prepared from rabbit skin at 24 hours, 
at the height of an Arthus type hypersensitivity reaction,  following the method described in 
previous papers (2, 4). The protein fraction has been called "proteolytic euglobuUn" by the 
authors,  because of its protease action.  The protein fraction was lyophilized. 
* This study is No. 7 of a series entitled Cytological Studies on Antigen-Antibody  Reaction 
in Tissue Culture.  It was aided  by a  Grant-in-Aid  for Fundamental  Scientific Research  of 
the Japanese Ministry of Education.  Part of it was presented  to a  meeting of the Japanese 
Society of Pathologists,  Osaka,  April  1, 1958. 
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RESULTS 
Appearance  of Protease-Inhibiting  Factor in the Culture Fluid.--Samples  of 
chamber fluid were taken at 30 minutes,  1,  12,  24,  36,  and 48 hour intervals 
after introduction of the antigen into the culture of monocytes collected from 
rabbits  sensitized  to  bovine  plasma  albumin.  The  sample,  collected  at  30 
minutes, is used as the protease sample; and 0.1  cc. of the sample can induce 
complete lysis of the fibrin clot in  about  15  hours of digestion.  Amounts of 
0.05 cc. of later samples were added  to the protease sample (0.1  cc.) and the 
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FIG. 1. Release of protease inhibitor into culture fluid. A, cellular protease (30 minute 
sample), 0.1 cc.; B, same with sample collected 12 hours after antigen application; C, with 
24 hour sample; D, with 36 hour sample; E, with 48 hour sample, e, sensitized cells (bovine 
plasma albumin); O, non-sensitized cells. 
Amounts of 0.05 cc. were used of all-inhibitor containing samples. Protease test at pH 7.4. 
mixtures  were allowed  to  stand  for  15  minutes  at  room temperature.  After 
that  the  mixtures  were  tested  for  protease  activity  following  the  method 
described in the preceding paper (1). The results are summarized in Fig. 1. 
The samples collected at 36 and 48 hours completely inhibited  the action of 
the  cellular protease; no demonstrable change  in  fibrin clot was found  even 
after 48 hours of digestion. The 12 to 24 hour samples were less inhibitory and 
the samples taken between 1 and 12 hours were inactive. 
Chamber fluid was also collected at various intervals after similar application 
of bovine serum albumin to cultured cells from non-sensitized or egg albumin- 
sensitized rabbits, and tested for the cellular protease. No inhibitor was found 
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E~idence Showing  That the Inhibitor  is Released from Cultured Cdls.--The 
cellular origin of the protease inhibitor was tested in the following way: 
(a)  One hour after application of the antigen, chamber fluid was collected 
(sample  1).  (b)  The  chamber  was  washed  thoroughly with  Gey's  solution 
(pH 7.2), the antigen applied again to the culture, and 12 hours later another 
sample was collected (sample 2).  (c) After washing the chamber, the antigen 
was introduced again, and 12 hours later sample 3 was collected. (d) Following 
the same procedure samples 4 and 5 were obtained from the same culture at 12 
hourly intervals. 
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l~o.  2. Inhibitor release after repeated application of antigen. A, cellular protease (30 
minute sample), 0A cc.; B, same with sample 1; C, with sample 2; D, with sample 3; E, with 
sample 4; F, with sample 5. For explanation of samples, see text. Protease test at pH 7.4. 
Amounts of 0.05 cc. of samples 2 to 5 were added to the protease (0.1  cc.), 
the mixtures were allowed to stand for 15 minutes at room temperature, and 
tested for protease activity. The results are summarized in Fig. 2. 
Fig.  2  shows  that  sample 3  was  clearly the  most active in inhibiting  the 
action of cellular protease; no demonstrable change in the clot was found in 
48 hours of digestion. This seemed to indicate that  the inhibitor is released 
from the cultured cells at a definite interval after the antigen-antibody reaction 
took place. The same type of experiment was done in  cultures from nonsen- 
sitized or egg albumin-sensitized rabbits, with negative results. 
Furthermore, an attempt was also made to test whether an inhibitor could 
be produced extracellularly from the antigen molecule (bovine plasma albumin) 
by the  action  of cellular protease released.  Sample  1,  which  contained  the 
protease and the antigen but not the inhibitor, was incubated for periods of 252  PROTEASE  INHIBITOR  FROM  CULTURED  CELLS 
6 to 24 hours at 37°C., and was tested for protease activity. The results excluded 
the possibility of an extracellular formation of the inhibitor. 
Effect of the Inhibitor on  Various Types of Proteases.--The  inhibiting effects 
of the culture fluid samples were tested on proteases other  than  the  cellular 
protease.  Crude papain (Merck)  was dissolved at  1.5  rag. per cc. in 0.85  per 
cent saline containing 2 X  10  -3 M cysteine and centrifuged. Crystalline trypsin 
(Armour)  was  dissolved  at  10  ~//cc.  in  saline.  Proteotytic  euglobulin  was 
dissolved at a concentration of 15 mg. per cc. in saline and centrifuged. 
ol/el 
20 
bJ 
I-- 
On  15 
03 
I--  IO  q 
X 
A  B  C  D  E  F 
FIG. 3. Effect of the inhibitor on various proteases. A, protease (0.25 cc.); B, with sample 
1; C, with sample 2; D, with sample 3; E, with sample 4; F, with sample 5. For identification 
of samples, see text. 
X, proteolytic euglobulin (15 rng. per cc.); O, papain (1.5 mg. per cc.); Q,  trypsin  (10 
#g. per cc.). 
All proteases tested at pH 7.4. 
Samples 1,  2, 3, 4, and 5 prepared as described above, were added to each 
protease solution, the mixtures were allowed to stand for  15 minutes at room 
temperature  and  tested  with  the  fibrin  clot  method  as  follows:  0.25  cc.  of 
protease solution, 0.05  cc. of the sample containing  the inhibitor  (or 0.05  cc. 
of saline), 0.05 cc. of 1 per cent fibrinogen (0.1  per cent at the final concentra- 
tion), 0.05  cc. of thrombin and 0.1  cc. of 0.1  M veronal buffer (pH 7.4).  The 
results are summarized in Fig. 3. 
As shown in  Fig.  3,  the action of papain, which  induced complete lysis of 
the fibrin clot in 5 minutes,  was completely inhibited  by the presence of the 
inhibitor (sample 3); in this case no demonstrable change in the clot was found 
even after 24 hours of digestion. The action of the proteolytic euglobulin was A.  TOKUDA, H.  HAYASHI~ AND K.  MATSUBA  253 
also  completely inhibited  (sample  3);  no clot lysis was found after  24 hours 
digestion  while in  the absence of the  inhibitor  the euglobulin produced com- 
plete lysis of the clot in 5 hours digestion. The effect of the inhibitor, however, 
was found negligible for trypsin? 
Partial  Purification  of the  Inhibiting  Factor.--Sample  3  was  used  as  the 
inhibitor-containing material.  To 5  cc. of the sample,  5  cc. of 6  per cent tri- 
chloracetic acid  was added,  and the mixture allowed to stand at 37°C. for 30 
minutes  until  precipitation  was  complete.  The  mixture  was  centrifuged  at 
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FIO. 4. Effect of partially  purified inhibitor on various proteases. A, protease; B, protease 
q- inhibitor; O, papain  (0.25 cc., 1.5 nag. per cc.); X, proteolytic euglobulln from rabbit  skin 
(0.25 cc., 15 nag. per cc.); C, cellular protease  (30 minute sample), 0.1 cc.; D, protease  + 
inhibitor. 
Inhibitor solution, used at 0.05 cc., contained  0.52 nag. N per cc., estimated  by micro- 
Kjeldahl method. Protease test at pH 7.4. 
5000  R.P.-.  for  10  minutes  and  filtered  through  Toyo-Roshi paper  No.  5C. 
The filtrate  was heated  to 80°C.  for 5  minutes,  cooled to 20°C., and filtered. 
The second filtrate was dialyzed through cellophane membrane against distilled 
water, with renewal,  for 72 to 96 hours at about 2°C. Precipitate in the cello- 
phane sack was collected and dissolved in 0.85 per cent saline.  The inhibiting 
effects of the precipitate on cellular protease, proteolytic euglobulin, and papain 
are shown in Fig. 4. No effect was observed on trypsin. 
1 As can be seen in Fig. 3, complete lysis of the clot by trypsin  was somewhat delayed 
in the presence of sample 3. This can, however, be ascribed to a trypsin inhibitor present in 
Cohn's fraction V used as antigen  (5). The same degree of inhibition was produced by addi- 
tion of 0.05 cc. of a 3 per cent solution of fraction V to trypsin. 254  PROTEASE  INHIBITOR  FROM  CULTURED  CELLS 
Partially purified inhibitor in  saline gave a  faint biuret  test,  and  it was 
found still active after 100°C. for 5  minutes 75°C. for 30 minutes of 0°C.  for 
24 hours. 
DISCUSSION 
The results just reported are interpreted as indicating the appearance of a 
protease  inhibitor at later stages  of  the antigen-antibody reaction.  As  was 
shown in the previous paper, the early stage is characterized by the release of 
a  protease.  Both, enzyme and inhibitor, are believed to be produced in  the 
cells and released into the culture fluid. 
Partial purification of the inhibitor collected in sample 3 yielded a substance 
not precipitated by 3 per cent trichloracetic acid, heat-stable and insoluble in 
distilled  water but soluble in saline. It gives a  faint biuret test and is non- 
dialyzable. 
The inhibitor is active against the protease released from cells by the antigen- 
antibody reaction,  the proteolytic euglobulin isolated from rabbit  skin and 
papain but has no effect on trypsin. It appears therefore different from other 
naturally occurring protease  inhibitors  (6,  7)  which  inactivate  trypsin  and 
other non-sulfhydryl proteases. It is difficult to determine the relationship of 
the inhibitor derived from monocytes with cathepsin inhibitors (8,  9)  which 
are at present incompletely isolated and characterized. 
It may be more closely related to an anti-protease isolated from rabbit skin 
in which an Arthus-type hypersensitivity was produced (2,  10-12).  This in- 
hibitor,  recently isolated in  crystalline form, also  inactivates the monocyte 
protease and papain but not trypsin. 
It seems probable that both the protease and its inhibitor are released by 
tissue phagocytes submitted  to  the  antigen-antibody reaction;  the  enzyme 
being  released  first,  the  inhibitor  later.  This  enzyme-inhibitor system,  the 
ratio between its two constituents and the succession of events in time may 
control the fate of the lesions produced in hypersensitivity phenomena. 
SITMMARY 
Decrease in the protease activity of the culture fluid observed at later stages 
of the antigen-antibody reaction is believed to be due to the release of an in- 
hibitor by the cells. The inhibitor was submitted to partial purification: it is 
heat-stable,  non-precipitated  by  trichloracetic  acid  and  non-dialyzable.  It 
inhibits certain cellular and tissue proteases and papain but is inactive against 
trypsin. It is suggested that the balance between protease and anti-protease 
released may detemdne the intensity, extent, and duration of certain sensitiza- 
tion phenomena. 
The authors are indebted to Dr. G. Ungar for his valuable suggestions and revision of the 
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